LecturaInvestigaciónRadarMarco de inversión
Iniciar sesión / Registrarse
← Volver a la lectura
NoticiasTema · 英矽智能AI长寿药Resumen rápido1 min de lecturaEditorial de DisconfirmAI

Insilico CEO Zhavoronkov on AI Anti-Aging

Fox Business features an exclusive interview with Insilico Medicine CEO Alex Zhavoronkov, PhD, exploring the potential applications of artificial intelligence in slowing aging.

2026-10-19 20:14 GMT+8

Insilico Medicine CEO Alex Zhavoronkov, PhD, was featured in an exclusive interview with Fox Business, discussing the potential of artificial intelligence to slow aging.

As the leader of an AI-driven drug discovery company, Zhavoronkov's perspective offers a professional view on AI applications at the frontier of life sciences. This video is recommended for readers interested in AI healthcare and anti-aging research.

Fuentes

  • youtube.com↗
Tema

英矽智能AI长寿药

美国生物技术公司英矽智能(Insilico Medicine)正试图通过生成式人工智能重塑长寿药物研发范式。该公司于2026年4月成立行业首个“长寿委员会”,由礼来高管担任主席,旨在打通前沿科学与大规模制药研发的壁垒。随后,英矽智能在9月发…

5 pasos2 piezasActualizado 2026-10-23 18:04

Cómo llegó hasta aquí

  1. 2026-04-21英矽智能宣布成立业界首个“长寿委员会”,由礼来分子发现集团副总裁Andrew Adams担任主席,Michael Levitt等科学家加入,旨在为AI赋能的衰老研究提供科学监督。
Iniciar sesión / Registrarse
LecturaInvestigaciónRadarMarco de inversión
prnasia.com ↗
  • 2026-09-07《自然·生物技术》发表研究,显示英矽智能AI发现的药物Rentosertib在IIa期临床试验中降低了六种独立蛋白质组学衰老时钟的生物学年龄。insilico.com ↗
  • 2026-09-17英矽智能联合团队在《细胞》杂志发表封面文章,推出LongevityBench、Longevity-LLMs和LongevityClaw组成的开源AI工具包,用于加速长寿研究。insilico.com ↗
  • Lo que aún está pendiente

    • FDA即将发布的监管科学优先领域文件将如何具体定义“衰老与长寿”的审批标准?
    • 英矽智能提出的“长寿疫苗”计划(基于环状mRNA和LNP)何时进入人体临床试验阶段?
    • 开源AI工具包LongevityBench能否被全球监管机构采纳为评估AI抗衰老药物的统一基准?

    También en este hilo

    • Insilico Medicine CEO Alex Zhavoronkov on AI in Longevity Therapeutics at ARDD 20262026-10-18
    • Insilico Medicine Releases Short Documentary on Open-Source AI Longevity Toolkit2026-10-18
    Leer el tema completo →
    Continuar investigando →